ARMCX1 and cholangiocarcinoma: The analysis with TIMER showed that ARMCX1 was drastically lower in various cancerous tissues, such as malignant bladder, breast, uterine neck, colon, kidney, lung, prostates, stomach, and thyroid; while ARMCX1 expression was higher in cholangiocarcinoma (Figure 1(a)).